Cellectar Biosciences, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Cellectar Biosciences, Inc. payments for repurchase of common stock for the quarter ending 2014-03-31 was $0.00.
- Cellectar Biosciences, Inc. payments for repurchase of common stock for the quarter ending 2013-12-31 was $0.00.
- Cellectar Biosciences, Inc. payments for repurchase of common stock for the quarter ending 2013-09-30 was $0.00.
- Cellectar Biosciences, Inc. payments for repurchase of common stock for the quarter ending 2013-06-30 was $0.00.
- Cellectar Biosciences, Inc. payments for repurchase of common stock for fiscal 2013 was $0.00.
- Cellectar Biosciences, Inc. payments for repurchase of common stock for fiscal 2012 was $0.00.
- Cellectar Biosciences, Inc. payments for repurchase of common stock for fiscal 2011 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 10-K · filed 2013-03-28 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |